Pfizer, Roche and Aspen face South African probe into cancer drug prices

PRETORIA (Reuters) – South Africa’s competition watchdog has launched an investigation into three drug companies accused of over-charging for cancer medicines, the agency’s chief said on Tuesday.


Reuters: Health News

About the author

Comments are closed.